833-2263234 (USA Toll-free) +1-224-345-1927 (USA) +86-13250544625(Intl) info@editxor.com
在线客服
[Literature Review] CRISPR Sparks Innovation: CreDiT Assay Redefines Diagnostics for Underserved Area

[Literature Review] CRISPR Sparks Innovation: CreDiT Assay Redefines Diagnostics for Underserved Area

EDITGENE provides CRISPR-based FASST detection technology and a range of CRISPR detection materials. With years of technical development and quality assurance, your order is just a click away!

[Weekly News] CRISPR-Cas9 Screening Technology Breaks Through the Limitations of Functional Genomic S

[Weekly News] CRISPR-Cas9 Screening Technology Breaks Through the Limitations of Functional Genomic S

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

[Literature Review] CRISPR Knockout: A Breakthrough in Nrf2 Activation for Kidney Disease Treatment

[Literature Review] CRISPR Knockout: A Breakthrough in Nrf2 Activation for Kidney Disease Treatment

EDITGENE focuses on gene editing, offering highly efficient gene knock-out services using an upgraded CRISPR/Cas9 system, which provides a higher positive rate and broader applicability across gene loci

[Weekly News] New Breakthrough in Cas Enzyme Structure: The First Structure of Type I-C NlaCas3 Enzym

[Weekly News] New Breakthrough in Cas Enzyme Structure: The First Structure of Type I-C NlaCas3 Enzym

EDITGENE focuses on CRISPR technology and is dedicated to providing the most efficient technical services for CRISPR-related research, gene function studies, in vitro diagnostics, and therapeutic research.

Prev 1 2 3 4 5 6 7 8 9 10 11 Next